Syncom Formulations (India) Limited (SYNCOMF) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.007x

Based on the latest financial reports, Syncom Formulations (India) Limited (SYNCOMF) has a cash flow conversion efficiency ratio of 0.007x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs17.58 Million ≈ $190.08K USD) by net assets (Rs2.70 Billion ≈ $29.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Syncom Formulations (India) Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Syncom Formulations (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Syncom Formulations (India) Limited carry for a breakdown of total debt and financial obligations.

Syncom Formulations (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Syncom Formulations (India) Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Namyong Terminal PCL BK:NYT	0.085x
Orion Office Reit Inc NYSE:ONL	0.009x
Kotra Industries Bhd KLSE:0002	0.017x
Private Equity Holding AG SW:PEHN	0.010x
Fiamma Holdings Bhd KLSE:6939	-0.039x
Paragon Care Limited F:PXS	0.001x
Orogen Royalties Inc V:OGN	0.015x
Apollo Silver Corp V:APGO	-0.106x

Annual Cash Flow Conversion Efficiency for Syncom Formulations (India) Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Syncom Formulations (India) Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Syncom Formulations (India) Limited.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs3.42 Billion ≈ $37.00 Million	Rs234.36 Million ≈ $2.53 Million	0.068x	+430.29%
2024-03-31	Rs2.87 Billion ≈ $31.07 Million	Rs-59.58 Million ≈ $-644.37K	-0.021x	-150.42%
2023-03-31	Rs2.56 Billion ≈ $27.69 Million	Rs105.29 Million ≈ $1.14 Million	0.041x	-44.03%
2022-03-31	Rs2.22 Billion ≈ $24.03 Million	Rs163.29 Million ≈ $1.77 Million	0.073x	+791.44%
2021-03-31	Rs1.88 Billion ≈ $20.29 Million	Rs-19.93 Million ≈ $-215.59K	-0.011x	-206.10%
2020-03-31	Rs1.46 Billion ≈ $15.75 Million	Rs-5.06 Million ≈ $-54.69K	-0.003x	-110.64%
2019-03-31	Rs1.33 Billion ≈ $14.34 Million	Rs43.29 Million ≈ $468.17K	0.033x	+348.68%
2018-03-31	Rs1.22 Billion ≈ $13.19 Million	Rs-16.01 Million ≈ $-173.10K	-0.013x	-111.13%
2017-03-31	Rs1.17 Billion ≈ $12.69 Million	Rs138.41 Million ≈ $1.50 Million	0.118x	-46.97%
2016-03-31	Rs1.09 Billion ≈ $11.76 Million	Rs241.74 Million ≈ $2.61 Million	0.222x	+11832.06%
2015-03-31	Rs1.00 Billion ≈ $10.84 Million	Rs1.87 Million ≈ $20.20K	0.002x	-97.36%
2014-03-31	Rs951.99 Million ≈ $10.30 Million	Rs67.30 Million ≈ $727.87K	0.071x	+7.30%
2013-03-31	Rs877.09 Million ≈ $9.49 Million	Rs57.79 Million ≈ $624.96K	0.066x	-14.20%
2012-03-31	Rs836.08 Million ≈ $9.04 Million	Rs64.20 Million ≈ $694.33K	0.077x	+281.55%
2011-03-31	Rs816.58 Million ≈ $8.83 Million	Rs-34.54 Million ≈ $-373.52K	-0.042x	-381.24%
2010-03-31	Rs550.47 Million ≈ $5.95 Million	Rs-4.84 Million ≈ $-52.32K	-0.009x	+51.59%
2009-03-31	Rs411.32 Million ≈ $4.45 Million	Rs-7.47 Million ≈ $-80.76K	-0.018x	-112.90%
2008-03-31	Rs390.34 Million ≈ $4.22 Million	Rs54.94 Million ≈ $594.11K	0.141x	-0.43%
2007-03-31	Rs342.37 Million ≈ $3.70 Million	Rs48.40 Million ≈ $523.37K	0.141x	+69.71%
2006-03-31	Rs292.59 Million ≈ $3.16 Million	Rs24.37 Million ≈ $263.55K	0.083x	--

About Syncom Formulations (India) Limited

NSE:SYNCOMF India Drug Manufacturers - Specialty & Generic

Market Cap

$149.13 Million

Rs13.79 Billion INR

Market Cap Rank

#17678 Global

#921 in India

Share Price

Rs14.67

Change (1 day)

-1.94%

52-Week Range

Rs10.30 - Rs22.15

All Time High

Rs26.77